Industry & regulation
The UK aesthetics market, and where the law is heading.
Non-surgical aesthetics has grown into a multi-billion-pound UK industry — but regulation of who can perform treatments like anti-wrinkle injections and dermal fillers is only now catching up. Here's what the numbers say, and what the government's incoming licensing scheme actually proposes.
Market growth
A fast-growing industry.
£3.2bn+
UK non-surgical aesthetics market value (2026)
Projected to pass £3.6bn in 2026 and reach around £5.1bn by 2028.
8–10%
Annual UK market growth rate
8–9% growth recorded in 2026, with ~10.2% annual growth projected through 2028.
19,701
Botulinum toxin (anti-wrinkle injection) practitioners in the UK
5,589
Clinics offering anti-wrinkle injections across the UK
~900,000
Anti-wrinkle injection treatments carried out annually in the UK
65%
Share of UK aesthetics revenue from injectable treatments
Regulation
What the government is actually proposing.
Section 180 of the Health and Care Act 2022 gives the UK government power to introduce a licensing scheme for non-surgical cosmetic procedures in England. The Department of Health and Social Care ran a public consultation between September and October 2023 and published its response in August 2025, based on 11,848 submissions — 60% of respondents backed a three-tier, risk-based classification system.
That system sorts procedures into three risk tiers, administered through local authority licensing for the lower tiers and Care Quality Commission oversight for the highest-risk category. It's a common misconception that this means every injectable treatment will become "doctors only" — it doesn't, quite. Here's the actual breakdown:
Green — low risk
Any licensed practitioner meeting agreed standards.
Examples: Microneedling, chemical peels, laser hair removal.
Amber — medium risk
Licensed non-healthcare practitioners under the oversight of a named, regulated healthcare professional — or performed independently by a qualified healthcare professional.
Examples: Anti-wrinkle injections, dermal fillers injected into the face.
Red — high risk
Restricted to suitably qualified, regulated healthcare professionals, delivered at CQC-regulated premises.
Examples: Body augmentation (e.g. breast, buttock or genital filler), extensive chemical peels.
In practice: anti-wrinkle injections and facial dermal fillers sit in the amber, medium-risk tier — a licensed non-healthcare practitioner can still perform them, but only under the named oversight of a regulated healthcare professional, while a qualified healthcare professional (doctor, dentist, nurse or pharmacist prescriber) can continue to perform them independently. The clearest push toward "medical professionals only" is in the red, high-risk tier — body augmentation procedures and more invasive treatments — which is restricted outright to regulated healthcare professionals at CQC-regulated premises.
The direction of travel is unmistakable, though: training standards, infection control requirements and licensing fees are still being finalised, with regulations expected to be phased in through 2025–2026 ahead of parliamentary approval and a transition period. Scotland has already moved independently — separate legislation passed the Scottish Parliament in March 2026, setting a minimum age of 18 for non-surgical cosmetic procedures.
We think that's the right direction. It's part of why our own approach at Aneeza Aesthetics already treats consultation, suitability checks and practitioner-led delivery as the baseline — not a box to tick once the law requires it.
What this means for you
Choosing a clinic in a changing landscape.
Until the licensing scheme is fully in force, standards still vary a lot between providers. The practical takeaway: ask who is actually administering your treatment, whether they're operating under healthcare professional oversight, and whether a proper consultation happens before anything is injected. See exactly what each treatment we offer involves — or get in touch if you'd rather ask us directly.
Continue reading
Where to go next.
Questions about how we operate?
We're happy to talk through our approach, qualifications and the regulatory landscape at consultation.
Enquire now